{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:57:04Z","timestamp":1772780224566,"version":"3.50.1"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1989,11,1]],"date-time":"1989-11-01T00:00:00Z","timestamp":625881600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1989,11]]},"DOI":"10.1007\/bf01869563","type":"journal-article","created":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T14:22:47Z","timestamp":1120227767000},"page":"797-813","source":"Crossref","is-referenced-by-count":17,"title":["Role of platelet inhibitor therapy in myocardial infarction"],"prefix":"10.1007","volume":"3","author":[{"given":"Bernardo","family":"Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01869563_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0046-8177(87)80330-1","volume":"18","author":"J Hawiger","year":"1987","unstructured":"Hawiger J. Formation and regulation of platelet and fibrin hemostatis plug.Human Pathol 1987: 18:111\u2013122.","journal-title":"Human Pathol"},{"key":"BF01869563_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/01.ATV.5.1.2","volume":"5","author":"MB Zucker","year":"1985","unstructured":"Zucker MB, Nachmias VT: Platelet activation.Arteriosclerosis 1985; 5:2\u201318.","journal-title":"Arteriosclerosis"},{"key":"BF01869563_CR3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/01.ATV.6.6.585","volume":"6","author":"R Mayne","year":"1986","unstructured":"Mayne R. Collagenous proteins of blood vessels.Arteriosclerosis 1986; 6:585\u2013593.","journal-title":"Arteriosclerosis"},{"key":"BF01869563_CR4","first-page":"13","volume-title":"Thrombosis and Platelets in Myocardial Ischemia. Cardiovascular Clinics","author":"JG White","year":"1987","unstructured":"White JG. Platelet structural physiology: The ultrastructure of adhesion. secretion, and aggregation in arterial thrombosis. In: Mehta JL (ed.)Thrombosis and Platelets in Myocardial Ischemia. Cardiovascular Clinics. Philadelphia: F.A. Davis, 1987:13\u201333."},{"issue":"Suppl B","key":"BF01869563_CR5","doi-asserted-by":"crossref","first-page":"2B","DOI":"10.1016\/S0735-1097(86)80002-X","volume":"8","author":"J Vermylen","year":"1986","unstructured":"Vermylen J, Verstraete M, Fuster V. Role of platelet activation and fibrin formation in thrombogenesis.J Am Coll Cardiol 1986; 8 (Suppl B):2B-9B.","journal-title":"J Am Coll Cardiol"},{"key":"BF01869563_CR6","first-page":"241","volume":"22","author":"EIB Peerschke","year":"1986","unstructured":"Peerschke EIB. The platelet fibrinogen receptor.Semin Hematol 1986; 22:241\u2013259.","journal-title":"Semin Hematol"},{"key":"BF01869563_CR7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1083\/jcb.103.2.451","volume":"103","author":"BS Coller","year":"1986","unstructured":"Coller BS. Activation affects access to the platelet receptor for adhesive glycoproteins.J Cell Biol 1986; 103:451\u2013456.","journal-title":"J Cell Biol"},{"key":"BF01869563_CR8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1056\/NEJM197905173002006","volume":"300","author":"S Moncada","year":"1979","unstructured":"Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.N Engl J Med 1979; 300:1142\u20131147.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/01.CIR.77.6.1213","volume":"77","author":"V Fuster","year":"1988","unstructured":"Fuster V, Badimon L, Cohen M, et al. Insights into the pathogenesis of acute ischemic syndromes.Circulation 1988; 77:1213\u20131220.","journal-title":"Circulation"},{"issue":"Suppl G","key":"BF01869563_CR10","doi-asserted-by":"crossref","first-page":"9G","DOI":"10.1016\/0002-9149(87)90586-8","volume":"60","author":"PC Adams","year":"1987","unstructured":"Adams PC, Fuster V, Badimon L, et al. Platelet vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: Preventive strategies.Am J Cardiol 1987; 60 (Suppl G):9G-16G.","journal-title":"Am J Cardiol"},{"key":"BF01869563_CR11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.ATV.6.3.312","volume":"6","author":"L Badimon","year":"1986","unstructured":"Badimon L, Badimon JJ, Galvez A, et al. Influence of arterial wall damage and wall shear rate on platelet deposition: Ex vivo study in a swine modelArteriosclerosis 1986; 6:312\u2013320.","journal-title":"Arteriosclerosis"},{"key":"BF01869563_CR12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/hrt.53.4.363","volume":"53","author":"MJ Davies","year":"1985","unstructured":"Davies MJ, Thomas AC. Plaque fissuring\u2014the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina.Br Heart J 1985; 53:363\u2013373.","journal-title":"Br Heart J"},{"key":"BF01869563_CR13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/hrt.50.2.127","volume":"50","author":"E Falk","year":"1983","unstructured":"Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi.Br Heart J 1983; 50:127\u2013134.","journal-title":"Br Heart J"},{"key":"BF01869563_CR14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.66.2.316","volume":"66","author":"DC Levin","year":"1982","unstructured":"Levin DC, Fallon JT. Significance of the angiographic morphology of localized coronary stenoses: Histopathologic correlations.Circulation 1982; 66:316\u2013320.","journal-title":"Circulation"},{"key":"BF01869563_CR15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0735-1097(85)80384-3","volume":"5","author":"JA Ambrose","year":"1985","unstructured":"Ambrose JA, Winters SL, Stern A, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris.J Am Coll Cardiol 1985; 5:609\u2013616.","journal-title":"J Am Coll Cardiol"},{"key":"BF01869563_CR16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198610093151501","volume":"315","author":"CT Sherman","year":"1986","unstructured":"Sherman CT, Litvack F, Grundfest W, et al. Coronary angioscopy in patients with unstable angina pectoris.N Engl J Med 1986; 315:913\u2013919.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0735-1097(86)80455-7","volume":"7","author":"JA Ambrose","year":"1986","unstructured":"Ambrose JA, Winters SL, Arora RR, et al. Angiographic evolution of coronary artery morphology in unstable angina.J Am Coll Cardiol 1986; 7:472\u2013478.","journal-title":"J Am Coll Cardiol"},{"key":"BF01869563_CR18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0735-1097(88)90356-7","volume":"12","author":"JA Ambrose","year":"1988","unstructured":"Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction.J Am Coll Cardiol 1988; 12:56\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"BF01869563_CR19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/01.CIR.78.5.1157","volume":"78","author":"WC Little","year":"1988","unstructured":"Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?Circulation 1988; 78:1157\u20131166.","journal-title":"Circulation"},{"key":"BF01869563_CR20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9149(85)90875-6","volume":"56","author":"G Capone","year":"1985","unstructured":"Capone G, Wolf NM, Meyer B, et al. Frequency of intracoronary filling defects by angiography in angina pectoris at rest.Am J Cardiol 1985; 56:403\u2013406.","journal-title":"Am J Cardiol"},{"key":"BF01869563_CR21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","volume":"315","author":"DJ Fitzgerald","year":"1986","unstructured":"Fitzgerald DJ, Roy L, Catella F, et al. Platelet activation in unstable coronary disease.N Engl J Med 1986; 315:983\u2013989.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.CIR.75.1.156","volume":"75","author":"P Theroux","year":"1987","unstructured":"Theroux P, Latour J-G, Leger C, et al. Fibrinopeptide A and platelet factor levels in unstable angina pectoris.Circulation 1987; 75:156\u2013162.","journal-title":"Circulation"},{"key":"BF01869563_CR23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.77.3.526","volume":"77","author":"K Gotoh","year":"1988","unstructured":"Gotoh K, Minamino T, Hatoh O, et al. The role of intracoronary thrombus in unstable angina: Angiographic assessment and thrombolytic therapy during ongoing anginal attacks.Circulation 1988; 77:526\u2013534.","journal-title":"Circulation"},{"key":"BF01869563_CR24","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.CIR.73.6.1186","volume":"73","author":"RS Gibson","year":"1986","unstructured":"Gibson RS, Beller GA, Gheorghiade M, et al. The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: A prospective natural history study.Circulation 1986; 73:1186\u20131198.","journal-title":"Circulation"},{"key":"BF01869563_CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/hrt.58.4.345","volume":"58","author":"AD Timmis","year":"1987","unstructured":"Timmis AD, Griffin B, Crick JCP, et al. The effects of early coronary patency on the evolution of myocardial infarction: A prospective arteriographic study.Br Heart J 1987; 58:345\u2013351.","journal-title":"Br Heart J"},{"key":"BF01869563_CR26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM198608143150703","volume":"315","author":"MA DeWood","year":"1986","unstructured":"DeWood MA, Stifter WF, Simpson CS, et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction.N Engl J Med 1986; 315:417\u2013423.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR27","first-page":"24","volume-title":"Thrombolysis in Cardiovascular Disease","author":"MJ Davies","year":"1989","unstructured":"Davies MJ. Thrombosis and coronary atherosclerosis. In: Julian DG, Kubler W, Norris RM, et al. (eds.)Thrombolysis in Cardiovascular Disease. New York: Marcel Dekker, 1989:24\u201343."},{"issue":"Suppl IV","key":"BF01869563_CR28","first-page":"IV","volume":"76","author":"L Badimon","year":"1987","unstructured":"Badimon L, Badimon JJ, Turitto VT, et al. Mechanisms of arterial thrombosis: Platelet thrombus deposition in areas of stenosis (abstract).Circulation 1987; 76 (Suppl IV):IV-102.","journal-title":"Circulation"},{"key":"BF01869563_CR29","first-page":"220","volume":"102","author":"CW Francis","year":"1983","unstructured":"Francis CW, Markahm RE Jr, Barlow GH, et al. Thrombin activity of fibrin thrombi and soluble plasmic derivatives.J Lab Clin Med 1983; 102:220\u2013230.","journal-title":"J Lab Clin Med"},{"issue":"Suppl B","key":"BF01869563_CR30","doi-asserted-by":"crossref","first-page":"21B","DOI":"10.1016\/S0735-1097(86)80004-3","volume":"8","author":"LA Harker","year":"1986","unstructured":"Harker LA, Fuster V. Pharmacology of platelet inhibitors.J Am Coll Cardiol. 1986; 8 (Suppl B):21B-32B.","journal-title":"J Am Coll Cardiol."},{"key":"BF01869563_CR31","first-page":"293","volume":"30","author":"S Moncada","year":"1978","unstructured":"Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin.Pharmacol Rev 1978; 30:293\u2013331.","journal-title":"Pharmacol Rev"},{"key":"BF01869563_CR32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1172\/JCI108941","volume":"61","author":"JW Burch","year":"1979","unstructured":"Burch JW, Stanford PW, Inhibition of platelet prostaglandin synthetase by oral aspirin.J Clin Invest 1979; 61:314\u2013319.","journal-title":"J Clin Invest"},{"key":"BF01869563_CR33","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI111865","volume":"75","author":"SR Hanson","year":"1985","unstructured":"Hanson SR, Harker LA, Bjornsson TD. Effect of plateletmodifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.J Clin Invest 1985; 75:1591\u20131599.","journal-title":"J Clin Invest"},{"key":"BF01869563_CR34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0049-3848(82)90127-X","volume":"25","author":"MR Buchanan","year":"1982","unstructured":"Buchanan MR, Riscke JA, Hirsh J. Aspirin inhibits platelet function independent of the acetylation of cyclooxygenase.Thromb Res 1982; 25:363\u2013373.","journal-title":"Thromb Res"},{"key":"BF01869563_CR35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI108132","volume":"56","author":"GL Roth","year":"1975","unstructured":"Roth GL, Majerus PW. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particular fraction protein.J Clin Invest 1975; 56:624\u2013632.","journal-title":"J Clin Invest"},{"key":"BF01869563_CR36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1172\/JCI109332","volume":"63","author":"EA Jaffe","year":"1979","unstructured":"Jaffe EA, Weksler BB. Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin.J Clin Invest 1979; 63:532\u2013535.","journal-title":"J Clin Invest"},{"key":"BF01869563_CR37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM198101083040203","volume":"304","author":"FE Preston","year":"1981","unstructured":"Preston FE, Whipps S, Jackson CA, et al. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.N Engl J Med 1981; 304:76\u201379.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.CIR.75.5.1025","volume":"75","author":"PA Kyrle","year":"1987","unstructured":"Kyrle PA, Eichler HG, Jager U, et al. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.Circulation 1987; 75:1025\u20131029.","journal-title":"Circulation"},{"key":"BF01869563_CR39","first-page":"452","volume":"36","author":"AW Clowes","year":"1977","unstructured":"Clowes AW, Karnovsky MJ. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rate.Lab Invest 1977; 36:452\u2013464.","journal-title":"Lab Invest"},{"key":"BF01869563_CR40","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.296.6618.316","volume":"296","author":"UK-TIA Study Group","year":"1988","unstructured":"UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Interim results.Br Med J 1988; 296:316\u2013320.","journal-title":"Br Med J"},{"key":"BF01869563_CR41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.296.6618.320","volume":"296","author":"Antiplatelet Trialists' Collaboration","year":"1988","unstructured":"Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment.Br Med J 1988; 296:320\u2013331.","journal-title":"Br Med J"},{"issue":"Suppl","key":"BF01869563_CR42","first-page":"12S","volume":"95","author":"J Hirsh","year":"1989","unstructured":"Hirsh J, Salzman EW, Harker L, et al. Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.Chest 1989; 95 (Suppl):12S-18S.","journal-title":"Chest"},{"key":"BF01869563_CR43","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-104-3-390","volume":"104","author":"DY Graham","year":"1986","unstructured":"Graham DY, Smith LJ. Aspirin and the stomach.Ann Intern Med 1986; 104:390\u2013398.","journal-title":"Ann Intern Med"},{"key":"BF01869563_CR44","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM198111123052002","volume":"305","author":"PL Friedman","year":"1981","unstructured":"Friedman PL, Brown EJ, Gunther S, et al. Coronary vasoconstrictor effect of indomethacin in patients with coronary artery disease.N Engl J Med 1981; 305:1171\u20131175.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR45","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0140-6736(78)91269-2","volume":"1","author":"S Moncada","year":"1978","unstructured":"Moncada S, Korbut R, Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.Lancet 1978; 1:1286\u20131289.","journal-title":"Lancet"},{"key":"BF01869563_CR46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1172\/JCI109831","volume":"66","author":"DJ Crutchley","year":"1980","unstructured":"Crutchley DJ, Ryan US, Ryan JW. Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery.J Clin Invest 1980; 66:29\u201335.","journal-title":"J Clin Invest"},{"key":"BF01869563_CR47","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM198705143162005","volume":"316","author":"GA FitzGerald","year":"1987","unstructured":"FitzGerald GA. Dipyridamole.N Engl J Med 1987; 316:1247\u20131257.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR48","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/01.CIR.62.3.449","volume":"62","author":"The Persantine-Aspirin Reinfarction Study Group","year":"1980","unstructured":"The Persantine-Aspirin Reinfarction Study Group. Persantine and aspirin in coronary heart disease.Circulation 1980; 62:449\u2013461.","journal-title":"Circulation"},{"key":"BF01869563_CR49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","volume":"14","author":"MG Bousser","year":"1983","unstructured":"Bousser MG, Eschwege E, Haugenau M, et al. \u201cAICLA\u201d controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia.Stroke 1983; 14:5\u201314.","journal-title":"Stroke"},{"key":"BF01869563_CR50","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.STR.16.3.406","volume":"16","author":"American-Canadian Cooperative Study Group","year":"1985","unstructured":"American-Canadian Cooperative Study Group. Persantine-aspirin trial in cerebral ischemia. Part II: Endpoint results.Stroke 1985; 16:406\u2013415.","journal-title":"Stroke"},{"key":"BF01869563_CR51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.72.1.138","volume":"72","author":"BG Brown","year":"1985","unstructured":"Brown BG, Cukingnan RA, DeRouen T, et al. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.Circulation 1985; 72:138\u2013146.","journal-title":"Circulation"},{"key":"BF01869563_CR52","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.CIR.77.6.1324","volume":"77","author":"S Goldman","year":"1988","unstructured":"Goldman S, Copeland J. Moritz T, et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: Results of a Veterans Administration Cooperative Study.Circulation 1988; 77:1324\u20131332.","journal-title":"Circulation"},{"key":"BF01869563_CR53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(85)91144-4","volume":"1","author":"H Hess","year":"1985","unstructured":"Hess H, Mietaschk A, Deichsel G. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease: A prospective double-blind ateriographically controlled trial.Lancet 1985; 1:415\u2013419.","journal-title":"Lancet"},{"key":"BF01869563_CR54","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM197012102832402","volume":"283","author":"LA Harker","year":"1970","unstructured":"Harker LA, Slichter SJ. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves.N Engl J Med 1970; 283:1302\u20131305.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR55","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJM197106242842501","volume":"284","author":"JM Sullivan","year":"1971","unstructured":"Sullivan JM, Harken DE, Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement.N Engl J Med 1971; 284:1391\u20131394.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR56","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0002-9149(83)90673-2","volume":"51","author":"JH Chesebro","year":"1983","unstructured":"Chesebro JH, Fuster V, Elveback LR, et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement. Danger of aspirin compared with dipyridamole.Am J Cardiol 1983; 51:1537\u20131541.","journal-title":"Am J Cardiol"},{"key":"BF01869563_CR57","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/01.CIR.60.4.910","volume":"60","author":"PP Steele","year":"1979","unstructured":"Steele PP, Rainwater J, Vogel R. Platelet suppressant therapy in patients with prosthetic cardiac valves: Relationship of clinical effectiveness to alteration of platelet survival time.Circulation 1979; 60:910\u2013913.","journal-title":"Circulation"},{"key":"BF01869563_CR58","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM197402072900604","volume":"290","author":"A Kaegi","year":"1974","unstructured":"Kaegi A, Pineo GF, Shimizu A, et al. Arteriovenous-shunt thrombosis: Prevention by sulfinpyrazone.N Engl J Med 1974; 290:304\u2013306.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR59","first-page":"237","volume":"1","author":"Report from the Anturan Reinfarction Italian Study","year":"1982","unstructured":"Report from the Anturan Reinfarction Italian Study. Sulfinpyrazone in post-myocardial infarction.Lancet 1982; 1:237\u2013242.","journal-title":"Lancet"},{"key":"BF01869563_CR60","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","volume":"313","author":"JA Cairns","year":"1985","unstructured":"Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina.N Engl J Med 1985; 313:1369\u201375.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM197807132990201","volume":"299","author":"Canadian Cooperative Study Group","year":"1978","unstructured":"Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke.N Engl J Med 1978; 299:53\u201359.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR62","first-page":"67","volume":"46","author":"H Lee","year":"1981","unstructured":"Lee H, Paton RC, Ruan C. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets (abstract).Thromb Haemost 1981; 46:67.","journal-title":"Thromb Haemost"},{"key":"BF01869563_CR63","first-page":"1","volume":"13","author":"JR O'Brien","year":"1983","unstructured":"O'Brien JR. Ticlopidine, a promise for the prevention and treatment of thrombosis and its complications.Haemostatis 1983; 13:1\u201354.","journal-title":"Haemostatis"},{"issue":"suppl A","key":"BF01869563_CR64","first-page":"238A","volume":"13","author":"F Violi","year":"1989","unstructured":"Violi F, Scrutinio, D, Cimminello C, et al. Study of Ticlopidine in Unstable Angina (S.T.A.I.) (abstract).J Am Coll Cardiol 1989; 13(suppl A):238A.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl IV","key":"BF01869563_CR65","first-page":"IV","volume":"76","author":"CW White","year":"1987","unstructured":"White CW, Chaitman B, Lassar TA, et al. Antiplatelet agents are effective in reducing the immediate complications of PTCA: Results from the ticlopidine multicenter trial (abstract).Circulation 1987; 76 (Suppl IV):IV-400.","journal-title":"Circulation"},{"key":"BF01869563_CR66","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0022-5223(19)36194-X","volume":"94","author":"R Limet","year":"1987","unstructured":"Limet R, David JL, Magotteaux P, et al. Prevention of aorta-coronary bypass graft occlusion.J Thorac Cardiovasc Surg 1987; 94:773\u2013783.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF01869563_CR67","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","volume":"1","author":"M Gent","year":"1989","unstructured":"Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.Lancet 1989; 1:1215\u20131220.","journal-title":"Lancet"},{"key":"BF01869563_CR68","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","volume":"321","author":"WK Hass","year":"1989","unstructured":"Hass WK, Eston JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the presentation of stroke in high-risk patients.N Engl J Med 1989; 321:501\u2013507.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR69","doi-asserted-by":"crossref","first-page":"890","DOI":"10.7326\/0003-4819-107-6-890","volume":"107","author":"C Schacky Von","year":"1987","unstructured":"Von Schacky C. Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy.Ann Intern Med 1987; 107:890\u2013899.","journal-title":"Ann Intern Med"},{"key":"BF01869563_CR70","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM198803033180905","volume":"318","author":"A Leaf","year":"1988","unstructured":"Leaf A, Weber PC. Cardiovascular effects in n-3 fatty acids.N Engl J Med 1988; 318:549\u2013557.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"BF01869563_CR71","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.1111\/j.1365-2125.1983.tb02114.x","volume":"15","author":"SR Reuben","year":"1983","unstructured":"Reuben SR, Kuan P, Cairns T, et al. Effects of dazoxiben and exercise performance in chronic stable angina.Br J Clin Pharmacol 1983; 15 (Suppl 1):83S-86S.","journal-title":"Br J Clin Pharmacol"},{"key":"BF01869563_CR72","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0002-9149(84)90074-2","volume":"53","author":"E Thaulow","year":"1984","unstructured":"Thaulow E, Dale J, Myhre E. Effects of a selective thromboxane synthetase inhibitor, dazoxiben, and of acetylsalicylic acid on myocardial ischemia in patients with coronary artery disease.Am J Cardiol 1984: 53:1255\u20131258.","journal-title":"Am J Cardiol"},{"key":"BF01869563_CR73","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0038-1661217","volume":"52","author":"P Gresele","year":"1984","unstructured":"Gresele P, Van Houtte E, Arnout J, et al. Thromboxane synthase inhibition combined with thromboxane receptor blockade. A step forward in antithrombotic strategy.Thromb Haemost 1984; 52:364.","journal-title":"Thromb Haemost"},{"key":"BF01869563_CR74","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0002-9343(82)90409-0","volume":"73","author":"MC Smith","year":"1982","unstructured":"Smith MC, Danviriyasup K, Crow JW, et al: Prostacyclin substitution for heparin in long-term hemodialysis.Am J Med 1982; 73:669\u2013678.","journal-title":"Am J Med"},{"key":"BF01869563_CR75","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0022-5223(19)37636-6","volume":"81","author":"D Coppe","year":"1981","unstructured":"Coppe D, Sobel M, Seavans L, et al. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.J Thorac Cardiovasc Surg 1981; 81:274\u2013278.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF01869563_CR76","first-page":"377","volume":"11","author":"Y Uchida","year":"1983","unstructured":"Uchida Y, Hanai T, Hasewaga K, et al. Recanalization of obstructed coronary artery by intracoronary administration of prostacyclin in patients with acute myocardial infarction.Adv Prostaglandin Thromboxand Leukotriene Res 1983; 11:377\u2013383.","journal-title":"Adv Prostaglandin Thromboxand Leukotriene Res"},{"key":"BF01869563_CR77","doi-asserted-by":"crossref","first-page":"24A","DOI":"10.1016\/0735-1097(88)92638-1","volume":"12","author":"EJ Topol","year":"1988","unstructured":"Topol EJ, Califf RM, George BS, et al. Insights derived from the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trials.J Am Coll Cardiol 1988; 12 (Suppl A):24A-31A.","journal-title":"J Am Coll Cardiol"},{"key":"BF01869563_CR78","first-page":"184","volume":"109","author":"CA Fisher","year":"1987","unstructured":"Fisher CA, Kappa JR, Sinha AK, et al. Comparison of equimolar concentrations of iloprost. prostacyclin, and prostaglandin E1 on human platelet function.J Lab Clin Med 1987; 109:184\u2013190.","journal-title":"J Lab Clin Med"},{"key":"BF01869563_CR79","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0002-9343(72)90033-2","volume":"52","author":"WC Roberts","year":"1972","unstructured":"Roberts WC, Buja LM. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. A study of 107 necropsy patients.Am J Med 1972; 52:425\u2013443.","journal-title":"Am J Med"},{"key":"BF01869563_CR80","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.ATV.9.1.109","volume":"9","author":"A Bini","year":"1989","unstructured":"Bini A, Fenoglio JJ, Mesa-Tejada R, et al. Identification and distribution of fibrinogen. fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.Arteriosclerosis 1989; 9:109\u2013121.","journal-title":"Arteriosclerosis"},{"key":"BF01869563_CR81","first-page":"349","volume":"2","author":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","year":"1988","unstructured":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2.Lancet 1988; 2:349\u2013360.","journal-title":"Lancet"},{"key":"BF01869563_CR82","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","volume":"309","author":"HD Lewis","year":"1983","unstructured":"Lewis HD, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study.N Engl J Med 1983; 309:396\u2013403.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR83","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","volume":"319","author":"P Theroux","year":"1988","unstructured":"Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina.N Engl J Med 1988; 319:1105\u20131111.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR84","doi-asserted-by":"crossref","unstructured":"Report of the Working Party on Anticoagulation Therapy in Coronary Thrombosis to the Medical Researh Council. Assessment of short-term anticoagulation administration after cardiac infarction.Br Med J 1969; 1:335\u2013342.","DOI":"10.1136\/bmj.1.5640.335"},{"key":"BF01869563_CR85","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1972.03210050013003","volume":"222","author":"A Drapkin","year":"1972","unstructured":"Drapkin A, Merskey C. Anticoagulation therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex and severity of infarction.JAMA 1972; 222:541\u2013548.","journal-title":"JAMA"},{"key":"BF01869563_CR86","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jama.1973.03220340034009","volume":"225","author":"Veterans Administration Hospital Investigators","year":"1973","unstructured":"Veterans Administration Hospital Investigators. Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial.JAMA 1973; 225:724\u2013729.","journal-title":"JAMA"},{"key":"BF01869563_CR87","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM197711172972004","volume":"297","author":"TC Chalmers","year":"1977","unstructured":"Chalmers TC, Matta RJ, Smith H, et al. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction.N Engl J Med 1977; 297:1091\u20131096.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR88","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM198902093200604","volume":"320","author":"AGG Turpie","year":"1989","unstructured":"Turpie AGG, Robinson JG, Doyle DJ, et al. Comparision of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.N Engl J Med 1989; 320:352\u2013357.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR89","first-page":"182","volume":"2","author":"The SCATI (Studio Sulla Calciparina nell'Angina & nella Trombosi Ventricolare nell'Imparto) Group","year":"1989","unstructured":"The SCATI (Studio Sulla Calciparina nell'Angina & nella Trombosi Ventricolare nell'Imparto) Group. Randomised controlled trial of subcutaneous calcium-haparin in acute myocardial infarction.Lancet 1989; 2:182\u2013186.","journal-title":"Lancet"},{"key":"BF01869563_CR90","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(81)92399-0","volume":"1","author":"AM Telford","year":"1981","unstructured":"Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.Lancet 1981; 1:1225\u20131228.","journal-title":"Lancet"},{"key":"BF01869563_CR91","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0002-9149(88)90924-1","volume":"61","author":"JA Ambrose","year":"1988","unstructured":"Ambrose JA, Hjemdahl-Monsen CE, Borrico S, et al. Angiographic demonstration of a common link between unstable angina pectoris and non-Q wave acute myocardial infarction.Am J Cardiol 1988; 61:244\u2013247.","journal-title":"Am J Cardiol"},{"key":"BF01869563_CR92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9149(89)91085-0","volume":"63","author":"KA Johennessen","year":"1989","unstructured":"Johennessen KA, Stratton JR, Taulow E, et al. Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction.Am J Cardiol 1989; 63:101\u2013102.","journal-title":"Am J Cardiol"},{"issue":"Suppl A","key":"BF01869563_CR93","doi-asserted-by":"crossref","first-page":"78A","DOI":"10.1016\/0735-1097(88)92644-7","volume":"12","author":"V Fuster","year":"1988","unstructured":"Fuster V, Stein B, Badimon L, et al. Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction.J Am Coll Cardiol 1988; 12 (Suppl A):78A-84A.","journal-title":"J Am Coll Cardiol"},{"key":"BF01869563_CR94","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0002-9149(86)90975-6","volume":"57","author":"AK Gash","year":"1986","unstructured":"Gash AK, Spann JF, Sherry S, et al. Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction.Am J Cardiol 1986; 57:175\u2013177.","journal-title":"Am J Cardiol"},{"key":"BF01869563_CR95","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/01.CIR.69.5.991","volume":"69","author":"DG Harrison","year":"1984","unstructured":"Harrison DG, Ferguson DW, Collins SM, et al. Rethrombosis after reperfusion with streptokinase: Importance of geometry of residual lesions.Circulation 1984; 69:991\u2013999.","journal-title":"Circulation"},{"key":"BF01869563_CR96","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0002-9149(87)91160-X","volume":"59","author":"RS Badger","year":"1987","unstructured":"Badger RS, Brown BG, Kennedy JW, et al. Usefulness of recanalization of luminal diameter of 0.6 millimeter or more with intracoronary streptokinase during acute myocardial infarction in predicting \u201cnormal\u201d perfusion status, continued arterial patency and survival at one year.Am J Cardiol 1987; 59:519\u2013522.","journal-title":"Am J Cardiol"},{"issue":"Suppl A","key":"BF01869563_CR97","first-page":"192A","volume":"11","author":"P Guise De","year":"1988","unstructured":"De Guise P, Theroux P, Bonan R, et al. Re-thrombosis after successful thrombolysis and angioplasty in acute myocardial infarction (abstract).J Am Coll Cardiol 1988; 11 (Suppl A):192A.","journal-title":"J Am Coll Cardiol"},{"key":"BF01869563_CR98","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM198903093201002","volume":"320","author":"TIMI Study Group","year":"1989","unstructured":"TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial.N Engl J Med 1989; 320:618\u2013627.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR99","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.1.5905.436","volume":"1","author":"PC Elwood","year":"1974","unstructured":"Elwood PC, Cochrane AL, Burr ML, et al. A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction.Br Med J 1974; 1:436\u2013440.","journal-title":"Br Med J"},{"key":"BF01869563_CR100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0021-9681(76)90020-5","volume":"29","author":"Coronary Drug Project Group","year":"1976","unstructured":"Coronary Drug Project Group. Aspirin in coronary heart disease.J Chronic Dis 1976; 29:625\u2013642.","journal-title":"J Chronic Dis"},{"key":"BF01869563_CR101","first-page":"157","volume-title":"Acetylsalicylic Acid in Cerebral Ischemia and Coronary Heart Disease","author":"K Uberla","year":"1978","unstructured":"Uberla K. Multicenter two-year prospective study onthe prevention of secondary myocardial infarction by ASA in comparison with phenprocoumon and placebo. In: Breddin K, Dorndorf W, Loew D, et al. (eds.)Acetylsalicylic Acid in Cerebral Ischemia and Coronary Heart Disease. Stuttgart: Schattauer, 1978:157\u2013169."},{"issue":"Suppl V","key":"BF01869563_CR102","first-page":"V63","volume":"62","author":"K Breddin","year":"1980","unstructured":"Breddin K, Loew D, Lechner K, et al. The German-Austrian Aspirin Trial: A comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction.Circulation 1980; 62 (Suppl V):V63-V72.","journal-title":"Circulation"},{"key":"BF01869563_CR103","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(79)92808-3","volume":"2","author":"PC Elwood","year":"1979","unstructured":"Elwood PC, Sweetnam PM. Aspirin and secondary mortality after myocardial infarction.Lancet 1979; 2:1313\u20131315.","journal-title":"Lancet"},{"key":"BF01869563_CR104","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.1980.03300330019023","volume":"243","author":"Aspirin Myocardial Infarction Study Research Group","year":"1980","unstructured":"Aspirin Myocardial Infarction Study Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction.JAMA 1980; 243:661\u2013669.","journal-title":"JAMA"},{"key":"BF01869563_CR105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJM198001313020502","volume":"302","author":"The Anturane Reinfarction Trial Research Group","year":"1980","unstructured":"The Anturane Reinfarction Trial Research Group. Sulfinpyrazone in the prevention of sudden death after myocardial infarction.N Engl J Med 1980; 302:250\u2013256.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR106","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJM198204223061640","volume":"306","author":"The Anturane Reinfarction Trial","year":"1982","unstructured":"The Anturane Reinfarction Trial: Reevaluation of outcome.N Engl J Med 1982; 306:1005\u20131008.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR107","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0735-1097(86)80489-2","volume":"7","author":"CR Klimt","year":"1986","unstructured":"Klimt CR, Knatterud GL, Stamler J, et al. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.J Am Coll Cardiol 1986; 7:251\u2013269.","journal-title":"J Am Coll Cardiol"},{"key":"BF01869563_CR108","first-page":"1172","volume":"1","author":"R Peto","year":"1980","unstructured":"Peto R. Aspirin after myocardial infarction (editorial).Lancet 1980; 1:1172\u20131173.","journal-title":"Lancet"},{"key":"BF01869563_CR109","doi-asserted-by":"crossref","unstructured":"Second Report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council. An assessment of long-term anticoagulant administration after cardiac infarction.Br Med J 1964; 2:837\u2013843.","DOI":"10.1136\/bmj.2.5413.837"},{"key":"BF01869563_CR110","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.1969.03150250093010","volume":"207","author":"RV Ebert","year":"1969","unstructured":"Ebert RV, Borden CW, Hipp HR, et al. Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration Cooperative Study.JAMA 1969; 207:2263\u20132267.","journal-title":"JAMA"},{"key":"BF01869563_CR111","doi-asserted-by":"crossref","unstructured":"Report of the Sixty Plus Reinfarction Study Research Group. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction.Lancet 1980; 2:989\u2013993.","DOI":"10.1016\/S0140-6736(80)92154-6"},{"key":"BF01869563_CR112","first-page":"203","volume":"1","author":"An International Anticoagulant Review Group","year":"1970","unstructured":"An International Anticoagulant Review Group. Collaborative analysis of long-term anticoagulant administration after acute myocardial infarction.Lancet 1970; 1:203\u2013209.","journal-title":"Lancet"},{"issue":"suppl","key":"BF01869563_CR113","first-page":"264","volume":"10","author":"P Smith","year":"1989","unstructured":"Smith P, Arnesan H. Oral anticoagulants reduce mortality, reinfarction and cerebrovascular events after myocardial infarction\u2014WARIS Study (abstract).Eur Heart J 1989; 10(suppl):264.","journal-title":"Eur Heart J"},{"key":"BF01869563_CR114","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198209163071201","volume":"307","author":"The E.P.S.I.M. Research Group","year":"1982","unstructured":"The E.P.S.I.M. Research Group. A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction.N Engl J Med 1982; 307:701\u2013708.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","volume":"321","author":"The Steering Committee of the Physicians' Health Study Research Group","year":"1989","unstructured":"The Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study.N Engl J Med 1989; 321:129\u2013135.","journal-title":"N Engl J Med"},{"key":"BF01869563_CR116","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","volume":"296","author":"R Peto","year":"1988","unstructured":"Peto R, Gray R, Collins R, et al. A randomized trial of the effects of prophylactic daily aspirin among male British doctors.Br Med J 1988; 296:313\u2013316.","journal-title":"Br Med J"},{"key":"BF01869563_CR117","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1056\/NEJM198907203210308","volume":"321","author":"V Fuster","year":"1989","unstructured":"Fuster V, Cohen M, Halparin JL. Aspirin in the prevention of coronary disease.N Engl J Med 1989; 321:183\u2013185.","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01869563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01869563\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01869563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T03:07:33Z","timestamp":1586315253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01869563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,11]]},"references-count":117,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1989,11]]}},"alternative-id":["BF01869563"],"URL":"https:\/\/doi.org\/10.1007\/bf01869563","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,11]]}}}